Citation Information :
Borruto F, Treisser A, Comparetto C. Prenatal Diagnosis, Where and How: No Way Out?. Donald School J Ultrasound Obstet Gynecol 2014; 8 (3):293-310.
Techniques for early diagnosis of the abnormal fetus. Clin Perinatol 1994;21(4):723-741.
Intrauterine fetal diagnosis for hematologic and other congenital disorders. Clin Lab Med 1999;19(1):239-253, vii-viii.
Prenatal diagnosis and screening. Dermatol Clin 1987;5(1):17-41.
Recent advances in noninvasive prenatal DNA diagnosis through analysis of maternal blood. J Obstet Gynaecol Res 2007;33(6):747-764.
Prenatal screening of single-gene disorders from maternal blood. Am J Pharmacogenomics 2001;1(2):111-117.
Fetal cells in maternal blood: their significance in noninvasive prenatal diagnosis and in etiologically determined diseases. Schweiz Med Wochenschr 1999;129(46):1740-1743.
Circulating nucleic acids in plasma/serum. Pathology 2007;39(2):197-207.
Isolation of fetal cells from the maternal circulation: prospects for the noninvasive prenatal diagnosis. Clin Chem Lab Med 2001;39(6):494-500.
Clinical Sciences Reviews Committee of the Association of Clinical Biochemists. Cell-free nucleic acids in plasma, serum and urine: a new tool in molecular diagnosis. Ann Clin Biochem 2003;40(Pt 2):122-130.
Application of fetal DNA in maternal plasma for noninvasive prenatal diagnosis. Expert Rev Mol Diagn 2002;2(1):32-40.
Prenatal assessment of fetal chromosomal and genetic disorders through maternal plasma DNA analysis. Pathology 2012;44(2):69-72.
Noninvasive prenatal diagnostic test accuracy for fetal sex using cell-free DNA a review and meta-analysis. BMC Res Notes 2012 Sep 1;5(9):476.
Recent progress in noninvasive prenatal diagnosis. Semin Fetal Neonatal Med 2008;13(2):57-62.
Noninvasive prenatal diagnosis by massively parallel sequencing of maternal plasma DNA. Open Biol 2012; 2(6):120086.
Post-genomics studies and their application to noninvasive prenatal diagnosis. Semin Fetal Neonatal Med 2008;13(2):91-98.
SAFE, the special noninvasive advances in fetal and neonatal evaluation network: aims and achievements. Prenat Diagn 2008;28(2):83-88.
The SAFE project: towards noninvasive prenatal diagnosis. Biochem Soc Trans 2009;37(Pt 2):460-465.
Proteomic technologies for prenatal diagnostics: advances and challenges ahead. Expert Rev Proteomics 2009;6(1):87-101.
Application of proteomics to prenatal screening and diagnosis for aneuploidies. Clin Chem Lab Med 2011;49(1):33-41.
Second trimester serum tests for Down's syndrome screening. Cochrane Database Syst Rev 2012;6:CD009925.
Noninvasive screening for chromosome abnormalities in young pregnant patients. Arch Gynecol Obstet 1992;252Suppl:S36-43.
UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998;352(9125):343-346.
Role of ultrasound evaluation of nuchal translucency in prenatal diagnosis. Clin Exp Obstet Gynecol 2002;29(4):235-241.
Ultrasound screening in pregnancy: advancing technology, soft markers for fetal chromosomal aberrations, and unacknowledged ethical dilemmas. Soc Sci Med 2003;56(10):2045-2057.
Noninvasive prenatal testing for fetal sex determination: is ultrasound still relevant? Eur J Obstet Gynecol Reprod Biol 2013 Sep 11. pii: S0301-2115(13)00455-457.
Role of the second-trimester ‘genetic sonogram’ for Down syndrome screen in the era of first-trimester screening and noninvasive prenatal testing. Prenat Diagn 2014 Jan 16.
Down's syndrome screening in pregnancies after assisted reproductive techniques: an update. Reprod Biomed Online 2002;4(3):285-293.
Cell-free fetal DNA and intact fetal cells in maternal blood circulation: implications for first and second trimester noninvasive prenatal diagnosis. Hum Reprod Update 2002;8(6):493-500.
Noninvasive prenatal diagnosis of fetal trisomy 21 using cell-free fetal DNA in maternal blood. Obstet Gynecol Sci 2013;56(2):58-66.
Fetal cells in transcervical samples at an early stage of gestation. J Hum Genet 2001;46(3):99-104.
Reliability of trans-cervical recovery of placental cells from the lower uterine pole using a minimally invasive procedure. Evidence based on fetal sexing and analysis of recovered cell populations. Early Hum Dev 1996;47Suppl:S99-102.
Fetal cells in cervical mucus and maternal blood. Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14(4):709-722.
Fetal cells in the maternal blood and prenatal diagnosis. Gynecol Obstet Fertil 2000;28(11):785-791.
Fetal cells in the mother: from genetic diagnosis to diseases associated with fetal cell microchimerism. Eur J Obstet Gynecol Reprod Biol 2000;92(1):103-108.
Human fetal mesenchymal stem cells. Curr Stem Cell Res Ther 2006;1(3):371-386.
Analysis of fetal blood cells in the maternal circulation: challenges, ongoing efforts, and potential solutions. Stem Cells Dev 2004;13(1):93-99.
Isolating fetal cells in maternal circulation for prenatal diagnosis. Prenat Diagn 1994;14(13):1229-1242.
Isolating fetal cells in the maternal circulation. Hum Reprod Update 1995;1(4):409-418.
Prenatal diagnosis using fetal cells isolated from maternal peripheral blood: a review. Clin Obstet Gynecol 1996;39(4):801-813.
Whole genome amplification from single cells in preimplantation genetic diagnosis and prenatal diagnosis. Eur J Obstet Gynecol Reprod Biol 2007;131(1):13-20.
The introduction of QF-PCR in prenatal diagnosis of fetal aneuploidies: time for reconsideration. Hum Reprod Update 2004;10(6):541-548.
New trends in noninvasive prenatal diagnosis: applications of dielectrophoresis-based Lab-on-a-chip platforms to the identification and manipulation of rare cells. Int J Mol Med 2008;21(1):3-12.
Current and emerging techniques of fetal cell separation from maternal blood. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878(22):1905-1911.
Novel approaches to manipulating foetal cells in the maternal circulation for noninvasive prenatal diagnosis of the unborn child. J Cell Biochem 2011;112(6):1475-1485.
From karyotyping to array-CGH in prenatal diagnosis. Cytogenet Genome Res 2011;135(3-4):241-250.
Microarray comparative genomic hybridization in prenatal diagnosis: a review. Ultrasound Obstet Gynecol 2012;40(4): 385-391.
Amniotic fluid stem cells and fetal cell microchimerism. Trends Mol Med 2013;19(5):271-272.
Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis. Ultrasound Obstet Gynecol 2013;41(6):610-620.
Characterization of fetal cells from the maternal circulation by microarray gene expression analysis -could the extravillous trophoblasts be a target for future cell-based noninvasive prenatal diagnosis? Fetal Diagn Ther 2014;35:218-227.
DNA-based prenatal diagnosis of heritable skin diseases. Arch Dermatol 1993;129(11):1455-1459.
Prenatal detection of fetal Down's syndrome from maternal plasma. Lancet 2000;356(9244):1819-1820.
Circulating fetal DNA in maternal plasma. Clin Chim Acta 2001;313(1-2):151-155.
Fetal DNA in maternal plasma: application to noninvasive blood group genotyping of the fetus. Transfus Clin Biol 2001;8(3):306-310.
Circulating (cell-free) nucleic acids – A promising, noninvasive tool for early detection of several human diseases. FEBS Lett 2007;581(5):795-799.
The use of cell-free fetal nucleic acids in maternal blood for noninvasive prenatal diagnosis. Hum Reprod Update 2009;15(1):139-151.
Genetic analysis of the fetus using maternal blood. Gynecol Obstet Fertil 2004;32(7-8):646-650.
Real-time PCR for prenatal and preimplantation genetic diagnosis of monogenic diseases. Mol Aspects Med 2006;27(2-3):176-191.
Noninvasive prenatal diagnosis and determination of fetal Rh status. Semin Fetal Neonatal Med 2008;13(2):63-68.
Prenatal typing of fetal DNA in cases of potential alloimmune haemolytic disease of the newborn: clinical benefit outweighs disadvantage. Br J Biomed Sci 1999;56(1):49-55.
Fetal RhD genotyping from maternal plasma. Ann Med 1999;31(5):308-312.
Noninvasive fetal RhD genotyping using maternal blood: time for use in all RhD negative pregnant women. Gynecol Obstet Fertil 2008;36(2):200-203.
Noninvasive fetal RHD genotyping tests: a systematic review of the quality of reporting of diagnostic accuracy in published studies. Eur J Obstet Gynecol Reprod Biol 2009;142(2):91-98.
Detection of circulating fetal nucleic acids: a review of methods and applications. J Clin Pathol 2009;62(4):308-313.
Noninvasive prenatal diagnosis by single molecule counting technologies. Trends Genet 2009;25(7):324-331.
Noninvasive diagnosis of fetal sex; utilisation of free fetal DNA in maternal plasma and ultrasound. Prenat Diagn 2006;26(7):598-603.
Noninvasive prenatal diagnosis using cell-free fetal DNA technology: applications and implications. Public Health Genomics 2010;13(4):246-255.
Noninvasive prenatal diagnosis by fetal nucleic acid analysis in maternal plasma: the coming of age. Semin Fetal Neonatal Med 2011;16(2):88-93.
Uses of cell free fetal DNA in maternal circulation. Best Pract Res Clin Obstet Gynaecol 2012;26(5):639-654.
The end of amniocentesis? From TriTest to PrenaTestTM. Donald School J Ultrasound Obstet Gynecol 2013;7(2):213-218.
Noninvasive prenatal diagnosis: public and patient perceptions. Semin Fetal Neonatal Med 2008;13(2):109-112.
Stress and anxiety associated with prenatal diagnosis. Best Pract Res Clin Obstet Gynaecol 2007;21(2):221-228.
Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21. Am J Obstet Gynecol 2005;193(2):322-326.
First trimester Down syndrome screening: public health implications. Semin Perinatol 2005;29(4):267-271.
Noninvasive prenatal diagnosis: implications for antenatal diagnosis and management of highrisk pregnancies. Semin Fetal Neonatal Med 2008;13(2):84-90.
Ethical aspects arising from noninvasive fetal diagnosis. Semin Fetal Neonatal Med 2008;13(2):103-108.
Universal screening for inherited metabolic diseases in the neonate (and the fetus). J Matern Fetal Neonatal Med 2012;25(Suppl 5):4-6.
Factors affecting the clinical use of noninvasive prenatal testing: a mixed methods systematic review. Prenat Diagn 2013;33(6):532-541.
The obstetrician's view: ethical and societal implications of noninvasive prenatal diagnosis. Prenat Diagn 2006;26(7):631-634.
Society of Obstetricians and Gynaecologists of Canada. Prenatal screening for fetal aneuploidy. J Obstet Gynaecol Can 2007;29(2):146-179.
Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada; Prenatal Diagnosis Committee of the Canadian College of Medical Geneticists. Prenatal screening for fetal aneuploidy in singleton pregnancies. J Obstet Gynaecol Can 2011;33(7):736-750.
Genetics Committee of the Society of Obstetricians and Gynaecologists of Canada; Prenatal Diagnosis Committee of the Canadian College of Medical Geneticists. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies. J Obstet Gynaecol Can 2011;33(7):754-767.
NSGC practice guideline: prenatal screening and diagnostic testing options for chromosome aneuploidy. J Genet Couns 2013;22(1):4-15.
Genetics Committee of the SOGC. Cell-free fetal DNA in the maternal circulation and its future uses in obstetrics. J Obstet Gynaecol Can 2005;27(1):54-62.
Noninvasive prenatal diagnosis of single gene disorders: how close are we? Semin Fetal Neonatal Med 2008;13(2):76-83.
Current status in noninvasive prenatal detection of down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma. J Obstet Gynaecol Can 2013;35(2):177-181.
Review: advances in noninvasive prenatal diagnosis. In Vivo 2013;27(2):165-170.
Circulating fetal DNA: its origin and diagnostic potential – a review. Placenta 2004;25Suppl A:S93-S101.
Fetal nucleic acids in maternal blood: the promises. Clin Chem Lab Med 2012;50(6):995-998.
Noninvasive aneuploidy detection using free fetal DNA and RNA in maternal plasma: recent progress and future possibilities. Hum Reprod Update 2011;17(3):372-382.
Genetic screening and diagnosis. Curr Opin Obstet Gynecol 2005;17(2):163-169.
Noninvasive prenatal diagnosis: on the horizon. Pharmacogenomics 2003;4(2):191-200.
Integration of genomics into medical practice. Discov Med 2013;16(89):241-248.
Rapid methods for targeted prenatal diagnosis of common chromosome aneuploidies. Semin Fetal Neonatal Med 2011;16(2):81-87.
Prenatal diagnosis: types and techniques. Early Hum Dev 2012;88(1):3-8.
Noninvasive prenatal diagnosis of single-gene disorders from maternal blood. Gene 2012;504(1):144-149.
Invasive procedures for prenatal diagnosis: any future left? Best Pract Res Clin Obstet Gynaecol 2012;26(5):625-638.
DNA methylation based biomarkers: practical considerations and applications. Biochimie 2012;94(11):2314-2337.
Noninvasive prenatal testing for Down syndrome. Semin Fetal Neonatal Med 2013 Nov 6. pii: S1744-165X(13)00095-4.
New genetic testing in prenatal diagnosis. Semin Fetal Neonatal Med 2013 Dec 3. pii: S1744-165X(13)00097-8.
Potential diagnostic consequences of applying noninvasive prenatal testing (NIPT): a population-based study from a country with existing first trimester screening. Ultrasound Obstet Gynecol 2014;43(3):265-271.
Clinical implementation of noninvasive prenatal testing among maternal fetal medicine specialists. Prenat Diagn 2014 May;34(5):416-423.